Literature DB >> 27062609

Rett-like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5-related disease.

L Allou1,2, S Julia3, D Amsallem4, S El Chehadeh5, L Lambert6,7, J Thevenon8,9, Y Duffourd9, A Saunier1, P Bouquet1, S Pere1, A Moustaïne1, L Ruaud4, V Roth1, P Jonveaux1,10, C Philippe1,10.   

Abstract

Several genes have been implicated in Rett syndrome (RTT) in its typical and variant forms. We applied next-generation sequencing (NGS) to evaluate for mutations in known or new candidate genes in patients with variant forms of Rett or Rett-like phenotypes of unknown molecular aetiology. In the first step, we used NGS with a custom panel including MECP2, CDKL5, FOXG1, MEF2C and IQSEC2. In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free. This missense was maternally inherited with opposite allele expression ratios in the proband and her mother. In the asymptomatic mother, the mutated copy of the CDKL5 gene was inactivated in 90% of blood cells. We also identified a premature stop codon (p.Arg926*) in IQSEC2 in a patient with a Rett-like phenotype. Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in KCNA2 encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of RTT. Our study expands the genetic heterogeneity of RTT and RTT-like phenotypes. Moreover, we report the first familial case of CDKL5-related disease.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CDKL5; IQSEC2; KCNA2; Rett syndrome; genetic heterogeneity; high-throughput sequencing

Mesh:

Substances:

Year:  2016        PMID: 27062609     DOI: 10.1111/cge.12784

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.

Authors:  Mark A Corbett; Susannah T Bellows; Melody Li; Renée Carroll; Silvana Micallef; Gemma L Carvill; Candace T Myers; Katherine B Howell; Snezana Maljevic; Holger Lerche; Elena V Gazina; Heather C Mefford; Melanie Bahlo; Samuel F Berkovic; Steven Petrou; Ingrid E Scheffer; Jozef Gecz
Journal:  Neurology       Date:  2016-10-12       Impact factor: 9.910

2.  Monogenic disorders that mimic the phenotype of Rett syndrome.

Authors:  Siddharth Srivastava; Sonal Desai; Julie Cohen; Constance Smith-Hicks; Kristin Barañano; Ali Fatemi; SakkuBai Naidu
Journal:  Neurogenetics       Date:  2018-01-10       Impact factor: 2.660

3.  Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy.

Authors:  Mirna Assoum; Christophe Philippe; Bertrand Isidor; Laurence Perrin; Periklis Makrythanasis; Neal Sondheimer; Caroline Paris; Jessica Douglas; Gaetan Lesca; Stylianos Antonarakis; Hanan Hamamy; Thibaud Jouan; Yannis Duffourd; Stéphane Auvin; Aline Saunier; Amber Begtrup; Catherine Nowak; Nicolas Chatron; Dorothée Ville; Kamiar Mireskandari; Paolo Milani; Philippe Jonveaux; Guylène Lemeur; Mathieu Milh; Masano Amamoto; Mitsuhiro Kato; Mitsuko Nakashima; Noriko Miyake; Naomichi Matsumoto; Amira Masri; Christel Thauvin-Robinet; Jean-Baptiste Rivière; Laurence Faivre; Julien Thevenon
Journal:  Am J Hum Genet       Date:  2016-11-23       Impact factor: 11.025

4.  Gonadal mosaicism of a novel IQSEC2 variant causing female limited intellectual disability and epilepsy.

Authors:  Lisa J Ewans; Michael Field; Ying Zhu; Gillian Turner; Melanie Leffler; Marcel E Dinger; Mark J Cowley; Michael F Buckley; Ingrid E Scheffer; Matilda R Jackson; Tony Roscioli; Cheryl Shoubridge
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

Review 5.  Further Clinical Delineation of the MEF2C Haploinsufficiency Syndrome: Report on New Cases and Literature Review of Severe Neurodevelopmental Disorders Presenting with Seizures, Absent Speech, and Involuntary Movements.

Authors:  Irena Vrečar; Josie Innes; Elizabeth A Jones; Helen Kingston; William Reardon; Bronwyn Kerr; Jill Clayton-Smith; Sofia Douzgou
Journal:  J Pediatr Genet       Date:  2017-04-12

Review 6.  Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review.

Authors:  Carlotta Spagnoli; Carlo Fusco; Francesco Pisani
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

7.  Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis.

Authors:  Sophie Nambot; Julien Thevenon; Paul Kuentz; Yannis Duffourd; Emilie Tisserant; Ange-Line Bruel; Anne-Laure Mosca-Boidron; Alice Masurel-Paulet; Daphné Lehalle; Nolwenn Jean-Marçais; Mathilde Lefebvre; Pierre Vabres; Salima El Chehadeh-Djebbar; Christophe Philippe; Frederic Tran Mau-Them; Judith St-Onge; Thibaud Jouan; Martin Chevarin; Charlotte Poé; Virginie Carmignac; Antonio Vitobello; Patrick Callier; Jean-Baptiste Rivière; Laurence Faivre; Christel Thauvin-Robinet
Journal:  Genet Med       Date:  2017-11-02       Impact factor: 8.822

8.  Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis.

Authors:  S J Hinze; M R Jackson; S Lie; L Jolly; M Field; S C Barry; R J Harvey; C Shoubridge
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

9.  CDKL5 variants: Improving our understanding of a rare neurologic disorder.

Authors:  Ralph D Hector; Vera M Kalscheuer; Friederike Hennig; Helen Leonard; Jenny Downs; Angus Clarke; Tim A Benke; Judith Armstrong; Mercedes Pineda; Mark E S Bailey; Stuart R Cobb
Journal:  Neurol Genet       Date:  2017-12-15

10.  Epilepsy and genetic in Rett syndrome: A review.

Authors:  Francesca Felicia Operto; Roberta Mazza; Grazia Maria Giovanna Pastorino; Alberto Verrotti; Giangennaro Coppola
Journal:  Brain Behav       Date:  2019-03-30       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.